Ming Yuan1, David White2, Linda Resar3, Eli Bar4, Mari Groves5, Alan Cohen5, Eric Jackson5, Jennifer Bynum1, Jeffrey Rubens3, Jeff Mumm2, Liam Chen1, Liqun Jiang1, Eric Raabe1, Fausto J Rodriguez1, Charles G Eberhart1. 1. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 2. Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 3. Division of Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 4. Department of Pathology, University of Maryland, Baltimore, Maryland, USA. 5. Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abstract
BACKGROUND: The conditional reprogramming cell culture method was developed to facilitate growth of senescence-prone normal and neoplastic epithelial cells, and involves co-culture with irradiated fibroblasts and the addition of a small molecule Rho kinase (ROCK) inhibitor. The aim of this study was to determine whether this approach would facilitate the culture of compact low-grade gliomas. METHODS: We attempted to culture 4 pilocytic astrocytomas, 2 gangliogliomas, 2 myxopapillary ependymomas, 2 anaplastic gliomas, 2 difficult-to-classify low-grade neuroepithelial tumors, a desmoplastic infantile ganglioglioma, and an anaplastic pleomorphic xanthoastrocytoma using a modified conditional reprogramming cell culture approach. RESULTS: Conditional reprogramming resulted in robust increases in growth for a majority of these tumors, with fibroblast conditioned media and ROCK inhibition both required. Switching cultures to standard serum containing media, or serum-free neurosphere conditions, with or without ROCK inhibition, resulted in decreased proliferation and induction of senescence markers. Rho kinase inhibition and conditioned media both promoted Akt and Erk1/2 activation. Several cultures, including one derived from a NF1-associated pilocytic astrocytoma (JHH-NF1-PA1) and one from a BRAF p.V600E mutant anaplastic pleomorphic xanthoastrocytoma (JHH-PXA1), exhibited growth sufficient for preclinical testing in vitro. In addition, JHH-NF1-PA1 cells survived and migrated in larval zebrafish orthotopic xenografts, while JHH-PXA1 formed orthotopic xenografts in mice histopathologically similar to the tumor from which it was derived. CONCLUSIONS: These studies highlight the potential for the conditional reprogramming cell culture method to promote the growth of glial and glioneuronal tumors in vitro, in some cases enabling the establishment of long-term culture and in vivo models.
BACKGROUND: The conditional reprogramming cell culture method was developed to facilitate growth of senescence-prone normal and neoplastic epithelial cells, and involves co-culture with irradiated fibroblasts and the addition of a small molecule Rho kinase (ROCK) inhibitor. The aim of this study was to determine whether this approach would facilitate the culture of compact low-grade gliomas. METHODS: We attempted to culture 4 pilocytic astrocytomas, 2 gangliogliomas, 2 myxopapillary ependymomas, 2 anaplastic gliomas, 2 difficult-to-classify low-grade neuroepithelial tumors, a desmoplastic infantile ganglioglioma, and an anaplastic pleomorphic xanthoastrocytoma using a modified conditional reprogramming cell culture approach. RESULTS: Conditional reprogramming resulted in robust increases in growth for a majority of these tumors, with fibroblast conditioned media and ROCK inhibition both required. Switching cultures to standard serum containing media, or serum-free neurosphere conditions, with or without ROCK inhibition, resulted in decreased proliferation and induction of senescence markers. Rho kinase inhibition and conditioned media both promoted Akt and Erk1/2 activation. Several cultures, including one derived from a NF1-associated pilocytic astrocytoma (JHH-NF1-PA1) and one from a BRAF p.V600E mutant anaplastic pleomorphic xanthoastrocytoma (JHH-PXA1), exhibited growth sufficient for preclinical testing in vitro. In addition, JHH-NF1-PA1 cells survived and migrated in larval zebrafish orthotopic xenografts, while JHH-PXA1 formed orthotopic xenografts in mice histopathologically similar to the tumor from which it was derived. CONCLUSIONS: These studies highlight the potential for the conditional reprogramming cell culture method to promote the growth of glial and glioneuronal tumors in vitro, in some cases enabling the establishment of long-term culture and in vivo models.
Authors: Brad Poore; Ming Yuan; Antje Arnold; Antoinette Price; Jesse Alt; Jeffrey A Rubens; Barbara S Slusher; Charles G Eberhart; Eric H Raabe Journal: Neuro Oncol Date: 2019-02-14 Impact factor: 12.300
Authors: Xuefeng Liu; Virginie Ory; Sandra Chapman; Hang Yuan; Chris Albanese; Bhaskar Kallakury; Olga A Timofeeva; Caitlin Nealon; Aleksandra Dakic; Vera Simic; Bassem R Haddad; Johng S Rhim; Anatoly Dritschilo; Anna Riegel; Alison McBride; Richard Schlegel Journal: Am J Pathol Date: 2011-12-18 Impact factor: 4.307
Authors: Xuefeng Liu; Ewa Krawczyk; Frank A Suprynowicz; Nancy Palechor-Ceron; Hang Yuan; Aleksandra Dakic; Vera Simic; Yun-Ling Zheng; Praathibha Sripadhan; Chen Chen; Jie Lu; Tung-Wei Hou; Sujata Choudhury; Bhaskar Kallakury; Dean G Tang; Thomas Darling; Rajesh Thangapazham; Olga Timofeeva; Anatoly Dritschilo; Scott H Randell; Christopher Albanese; Seema Agarwal; Richard Schlegel Journal: Nat Protoc Date: 2017-01-26 Impact factor: 13.491
Authors: Chrysiis Michaloglou; Liesbeth C W Vredeveld; Maria S Soengas; Christophe Denoyelle; Thomas Kuilman; Chantal M A M van der Horst; Donné M Majoor; Jerry W Shay; Wolter J Mooi; Daniel S Peeper Journal: Nature Date: 2005-08-04 Impact factor: 49.962
Authors: Chuan Yan; Dalton C Brunson; Qin Tang; Daniel Do; Nicolae A Iftimia; John C Moore; Madeline N Hayes; Alessandra M Welker; Elaine G Garcia; Taronish D Dubash; Xin Hong; Benjamin J Drapkin; David T Myers; Sarah Phat; Angela Volorio; Dieuwke L Marvin; Matteo Ligorio; Lyle Dershowitz; Karin M McCarthy; Murat N Karabacak; Jonathan A Fletcher; Dennis C Sgroi; John A Iafrate; Shyamala Maheswaran; Nick J Dyson; Daniel A Haber; John F Rawls; David M Langenau Journal: Cell Date: 2019-04-25 Impact factor: 41.582
Authors: Juliane L Buhl; Florian Selt; Thomas Hielscher; Romain Guiho; Jonas Ecker; Felix Sahm; Johannes Ridinger; Dennis Riehl; Diren Usta; Britta Ismer; Alexander C Sommerkamp; J P Martinez-Barbera; Annika K Wefers; Marc Remke; Daniel Picard; Stefan Pusch; Jan Gronych; Ina Oehme; Cornelis M van Tilburg; Marcel Kool; Daniela Kuhn; David Capper; Andreas von Deimling; Martin U Schuhmann; Christel Herold-Mende; Andrey Korshunov; Tilman Brummer; Stefan M Pfister; David T W Jones; Olaf Witt; Till Milde Journal: Clin Cancer Res Date: 2018-12-07 Impact factor: 12.531
Authors: Abdul M Mondal; Hua Zhou; Izumi Horikawa; Frank A Suprynowicz; Guangzhao Li; Aleksandra Dakic; Bernard Rosenthal; Lin Ye; Curtis C Harris; Richard Schlegel; Xuefeng Liu Journal: Cell Death Dis Date: 2018-07-03 Impact factor: 8.469
Authors: Dorine A Bax; Suzanne E Little; Nathalie Gaspar; Lara Perryman; Lynley Marshall; Marta Viana-Pereira; Tania A Jones; Richard D Williams; Anita Grigoriadis; Gilles Vassal; Paul Workman; Denise Sheer; Rui M Reis; Andrew D J Pearson; Darren Hargrave; Chris Jones Journal: PLoS One Date: 2009-04-14 Impact factor: 3.240
Authors: Yuan Pan; Min Xiong; Ran Chen; Yu Ma; Courtney Corman; Meron Maricos; Urs Kindler; Marcus Semtner; Yi-Hsien Chen; Sonika Dahiya; David H Gutmann Journal: Genes Dev Date: 2018-04-09 Impact factor: 11.361
Authors: Christopher M Rota; Alexander T Brown; Emily Addleson; Clara Ives; Ella Trumper; Kristine Pelton; Wei Pin Teh; Matthew J Schniederjan; Robert Craig Castellino; Sara Buhrlage; Douglas A Lauffenburger; Keith L Ligon; Linda G Griffith; Rosalind A Segal Journal: Neurooncol Adv Date: 2022-04-13
Authors: Ming Yuan; Charles G Eberhart; Christine A Pratilas; Jaishri O Blakeley; Christine Davis; Marija Stojanova; Karlyne Reilly; Alan K Meeker; Christopher M Heaphy; Fausto J Rodriguez Journal: Cancers (Basel) Date: 2022-06-19 Impact factor: 6.575
Authors: Kalil G Abdullah; Cylaina E Bird; Joseph D Buehler; Lauren C Gattie; Milan R Savani; Alex C Sternisha; Yi Xiao; Michael M Levitt; William H Hicks; Wenhao Li; Denise M O Ramirez; Toral Patel; Tomas Garzon-Muvdi; Samuel Barnett; Gao Zhang; David M Ashley; Kimmo J Hatanpaa; Timothy E Richardson; Samuel K McBrayer Journal: Neuro Oncol Date: 2022-04-01 Impact factor: 13.029
Authors: Corina Anastasaki; Jit Chatterjee; Olivia Cobb; Shilpa Sanapala; Suzanne M Scheaffer; Amanda De Andrade Costa; Anna F Wilson; Chloe M Kernan; Ameera H Zafar; Xia Ge; Joel R Garbow; Fausto J Rodriguez; David H Gutmann Journal: Acta Neuropathol Commun Date: 2022-08-19 Impact factor: 7.578
Authors: Till Milde; Fausto J Rodriguez; Jill S Barnholtz-Sloan; Nirav Patil; Charles G Eberhart; David H Gutmann Journal: Neuro Oncol Date: 2021-10-01 Impact factor: 13.029